home / stock / oncy / oncy news


ONCY News and Press, Oncolytics Biotech Inc. From 08/04/23

Stock Information

Company Name: Oncolytics Biotech Inc.
Stock Symbol: ONCY
Market: NASDAQ
Website: oncolyticsbiotech.com

Menu

ONCY ONCY Quote ONCY Short ONCY News ONCY Articles ONCY Message Board
Get ONCY Alerts

News, Short Squeeze, Breakout and More Instantly...

ONCY - Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference

Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference Canada NewsWire SAN DIEGO and CALGARY, AB , Aug. 4, 2023 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that...

ONCY - CTXR, ONCY and CKPT among pre-market losers

2023-07-31 08:19:22 ET Checkpoint Therapeutics ( CKPT ) -14% announces $10 Million registered direct offering priced at-the-market. Citius Pharmaceuticals ( CTXR ) -13% . BioNexus Gene Lab Corp. ( BGLC ) -13% . Blue Star Foods Corp. ( BSFC ) -...

ONCY - Oncolytics Biotech® Announces US$15 Million Bought Deal Offering of Units

Oncolytics Biotech® Announces US$15 Million Bought Deal Offering of Units Canada NewsWire Not for distribution to U.S. Newswire Services or Dissemination in the United States CALGARY, AB , July 31, 2023 /CNW/ -- Oncolytics Biotech ® ...

ONCY - BTBT, ONCY and AMRX among pre-market losers

2023-07-05 08:14:54 ET Amneal Pharmaceuticals ( AMRX ) -13% . Advanced Health Intelligence ( AHI ) -10% . Landos Biopharma ( LABP ) -10% . InterCure ( INCR ) -9% . Alliance Entertainment Holding Corporation ( AENT ) -9% . Renalyt...

ONCY - Oncolytics: Proof Of Concept In 2 Large Market Indications

2023-07-03 17:39:47 ET Summary Positive results achieved, in using pelareorep + paclitaxel for the treatment of HR+/HER2- metastatic breast cancer patients, in the phase 2 BRACELET-1 study. Preparation is underway to initiate a phase 3 study using pelareorep + paclitaxel for the t...

ONCY - Oncolytics Biotech: Back In The Spotlight With 2 Potential Catalysts

2023-07-01 03:28:37 ET Summary Today, we put a small oncology-focused biotech firm called Oncolytics Biotech in the spotlight for the first time in over two years. Its primary pipeline asset is heading towards pivotal Phase 3 development as part of a combination therapy for two di...

ONCY - RenovoRx, Immunome top healthcare gainers; BioXcel, CorMedix among losers

2023-06-29 10:10:59 ET Gainers: RenovoRx ( RNXT ) +37% . Immunome ( IMNM ) +36% .  DermTech ( DMTK ) +15% . Galera Therapeutics ( GRTX ) +9% . Oncolytics Biotech ( ONCY ) +7% . Losers: BioXcel Therapeutics ( BTA...

ONCY - Minerva, Regional Health top healthcare gainers; Cognition, Eton among losers

2023-06-28 10:09:16 ET Gainers: Minerva Neurosciences ( NERV ) +51% . Regional Health Properties ( RHE ) +12% . Genfit ( GNFT ) +11% . RenovoRx ( RNXT ) +11% . OPKO Health ( OPK ) +5% . Losers: Cognition Therapeutics ( C...

ONCY - AULT, KC and ADES among mid-day movers

2023-06-23 13:11:51 ET Gainers: Ault Alliance ( AULT ) +21% . Smith & Wesson Brands ( SWBI ) +19% . Oncolytics Biotech ( ONCY ) +18% . Lyra Therapeutics ( LYRA ) +19% . Argo Blockchain ( ARBK ) +16% . Golden Heaven Group ...

ONCY - Oncolytics up 54% in last three trading sessions

2023-06-23 12:53:42 ET Oncolytics Biotech ( NASDAQ: ONCY ) is up an impressive 54% since the market close on June 20. In early afternoon trading Friday, the stock is up 17% . The reason for the jump is that its oncologic pelareorep has been selected f...

Previous 10 Next 10